382 results on '"Blackford, Amanda L."'
Search Results
2. Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer
3. Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery
4. ASO Visual Abstract: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery
5. Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer
6. Rural–Urban Disparities in Mortality and Place of Death for Gastrointestinal Cancer in the United States From 2003 to 2019
7. Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer
8. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote
9. Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation
10. A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML
11. Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia
12. A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO
13. Is federal housing assistance associated with earlier-stage cancer diagnosis? Evidence from the new SEER-Medicare and US Department of Housing and Urban Development data linkage.
14. Assessing and enhancing legal literacy in cancer care: A nationwide analysis of a training intervention for healthcare workers.
15. Housing assistance among patients with cancer: SEER-Medicare US Department of Housing and Urban Development data linkage.
16. Geographic Disparities in Head and Neck Cancer Mortality and Place of Death.
17. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals.
18. Cancer spectrum and outcomes in the Mendelian short telomere syndromes
19. Interpreting and Acting on PRO Results in Clinical Practice : Lessons Learned From the PatientViewpoint System and Beyond
20. In proportion : approaches for displaying patient-reported outcome research study results as percentages responding to treatment
21. The effect of 1-day multidisciplinary clinic on breast cancer treatment
22. Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS
23. A randomized intervention involving family to improve communication in breast cancer care
24. Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
25. Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer.
26. Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
27. Underutilization of Treatment for Regional Gastric Cancer Among the Elderly in the USA
28. Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?
29. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy
30. Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation
31. Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
32. Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation.
33. Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA
34. The Significance of Ascites in Patients With Pancreatic Ductal Adenocarcinoma: A Case-Control Study
35. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors
36. Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma
37. Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
38. Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs
39. Concerns Regarding the Utility of High-Risk Pancreatic Cancer Surveillance—Reply.
40. T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers
41. Early Identification of Intracranial Hemorrhage Using a Predictive Nomogram
42. Local Social Vulnerability as a Predictor for Cancer-Related Mortality Among US Counties.
43. Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins
44. Improving an electronic system for measuring PROs in routine oncology practice
45. PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
46. Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute
47. Rural-urban disparities in place of death in hematologic malignancies in the United States, 2003 to 2019
48. Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention
49. A two-stage approach to genetic risk assessment in primary care
50. Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.